Advertisement

Physician's First Watch Archive

Medical news from NEJM Journal Watch

October 21, 2014

By the Editors

NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:

NEJM Live Ebola Webcast: Don't miss the live …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Patients who are aware of their risk for colorectal cancer, as assessed by genetic and environmental factors, are no more likely than others to undergo …

By Amy Orciari Herman

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Dopamine receptor agonists — used to treat Parkinson disease, restless leg syndrome, and hyperprolactinemia — confer high risk for impulse control disorders, and their labels should carry stronger warnings about this risk, researchers conclude …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Approximately one in five healthcare workers may not be able to recall whether their patients have central venous catheters (CVCs), according …

By Kelly Young

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Children who drink non-cow's milk — such as soy, rice, almond, or goat's milk — have lower serum vitamin D levels than those …

By Joe Elia

Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD

Forty-three contacts of the first Ebola case diagnosed in the U.S. have been declared …

October 20, 2014

By the Editors

Join the NEJM live audio webcast on the Ebola outbreak on …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD

The FDA has approved new labeling to highlight the abuse-deterrent properties of extended-release Embeda (morphine sulfate and naltrexone hydrochloride), an oral …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD

An FDA advisory panel voted late last week to keep the black-box warning on the smoking cessation drug varenicline …

By Amy Orciari Herman

Edited by Susan Sadoughi, MD

New guidelines under development by the CDC for healthcare workers treating Ebola-infected patients will mandate personal protective gear that allows no skin to show, Anthony Fauci, director of the National Institute of Allergy …

Pages